The following are the headlines discussed at Aldwin Callen's Monday morning briefing:
- As a result of the coronavirus, China's economy declined 6.8 percent in the first quarter of 2020, the largest drop in GDP since at least 1992.
- Oil prices plunged 39% to a 21-year low, as sinking global demand is causing a global supply glut and uncertainty about storage.
- Remdesivir, a medicine developed by Gilead Scientific, is showing promise in treating critically unwell Covid-19 patients; the treatment is currently in late-stage clinical trials.
- US retail sales declined 8.7 percent in March, the largest dip since the US government began tracking this figure in 1992, as individuals and businesses choose to stay at home across the majority of the country.
- US builders began work on 22% fewer homes in March compared to February, the worst monthly decline since 1984; nevertheless, new building permits fell by only 6.8 percent.
Important Information
Aldwin Callen's wealth management may provide you information about its products and services through this material. The information presented here may not be appropriate for all investors, and there are risks associated with making an investment based on the ideas presented.
This document may contain information regarding Aldwin Callen' brokerage and investment advising services. We encourage clients to speak with their Aldwin Callen representative about the products and services they are considering and to clarify any questions they may have about the distinction between brokerage and investment advisory services, including the obligation to disclose conflicts of interest and act in their best interests.
Aldwin Callen may hold a position for itself or one of our other clients that is inconsistent with the information, opinions, estimates, investment strategies, or viewpoints contained in this paper. Aldwin Callen or its affiliates may maintain a stake in or operate as a market maker in any of the financial instruments discussed herein, or act as an underwriter, placement agency, advisor, or lender to such issuer.
© 2020 Aldwin Callen. All Rights Reserved.